ELX-02

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X AlleleNCT04126473ELOXPhase 2Completed2022-04-06Actual
A Study of ELX-02 in Patients With Alport SyndromeNCT05448755ELOXPhase 2Completed2023-09-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.